跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFUFIRST - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
CEFUFIRST
Approved
STANDARD
CEFUFIRST
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
460f91020ecea711
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
460f91020ecea711
Drug Approval Philippines Name
CEFUFIRST
Product Name
CEFUFIRST
Registration Number
DRP-7543
Brand Name
CEFUFIRST
Generic Name
CEFUROXIME (AS AXETIL)
Dosage Form
Granules For Oral Suspension
Dosage Strength
250mg/5mL
Manufacturer
J.M. Tolmann Laboratories, Inc.
Distributor
Firstmed Theraconcept Inc.
Issuance Date
28 May 2024
Expiry Date
14 October 2029
Pharmacologic Category
ANTIBACTERIAL (CEPHALOSPORINS)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
460f91020ecea711
Type
Standard
Back to Philippines FDA Approvals